The Australian Global Health Alliance is delighted to welcome UNSW’s School of Population Health as the newest member of the Alliance. The University of New South Wales’s School of Population Health is the oldest and largest health management program in Australia, ranked top 50 globally for public health research. The school’s work ranges from responding to […]
Thursday, December 2, 2021 Australia’s leading epidemiologists, global health, business, development and aid organisations have united to call on the Federal Government to urgently ramp up its global vaccination efforts following the emergence of the Omicron variant. The coalition, brought together by End COVID For All, includes the Business Council of Australia, the Australian Global […]
Thursday, December 2, 2021 Australia’s leading epidemiologists, global health, business, development and aid organisations have united to call on the Federal Government to urgently ramp up its global vaccination efforts following the emergence of the Omicron variant. The coalition, brought together by End COVID For All, includes the Business Council of Australia, the Australian Global […]
GENEVA – The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria today unanimously approved a new response mechanism to support countries to respond to COVID-19 and mitigate the impact on programs to fight HIV, TB, malaria and systems for health, effectively doubling the amount of available funding to up to US$1 billion. The […]
06 October 2021 WHO recommendation for wider use of the RTS,S malaria vaccine is largely based on data gathered during malaria vaccine pilots which took place in Kenya, Ghana and Malawi Gavi, the Vaccine Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria and global health agency Unitaid have together committed nearly US$ 70 […]
Global leaders rally to accelerate access to COVID-19 vaccines for lower-income countries The “One World Protected” Event, hosted today by the United States and Gavi, the Vaccine Alliance, launched a campaign to raise US$ 2 billion for the global fight against COVID-19. The additional funding from donors and countries with MDB support will enable the […]
Unitaid funding sees launch of world’s first long-acting medicines centre at University of Liverpool Geneva, 12 January 2021 – Efforts to revolutionise treatments for debilitating infectious diseases have been amplified today with the launch of a new research centre at the University of Liverpool. Established as part of a US$40 million international research consortium, primarily funded by […]
The United States has approved US$ 4 billion for Gavi, the Vaccine Alliance to ensure lower-income economies have equitable access to safe and effective COVID-19 vaccines on the same urgent timeline as wealthier countries. These funds will help end this acute phase of the pandemic. The United States also approved its Fiscal Year 2021 contribution […]
COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors These agreements mean that all COVAX’s 190 participating and eligible economies will be able to access doses to protect vulnerable groups in the first […]
Global Fund COVID-19 Situation Report – 28 July 2020 Global cases: 16,301,736 confirmed. Global deaths: 650,069 confirmed. Countries, areas or territories with cases: 216 (as of 28 July, WHO). On 25 July, WHO reported the biggest single-day rise in global COVID-19 infections since the pandemic started. China recorded highest new COVID-19 cases since April after fresh clusters […]
Global Fund COVID-19 Situation Report – 21 July 2020 Global cases: : 14,348,858 confirmed. Global deaths: 603,691 confirmed. Countries, areas or territories with cases: 216 (as of 14 July, WHO). As COVID-19 cases and deaths continue rising globally, WHO expressed deep concerns about COVID-19 impact on indigenous people, especially at risk. WHO also warned of a decline […]
The COVAX pillar aims to ensure that the most viable COVID19 vaccine candidates get the support needed to succeed, and are then produced at scale to reach everyone, everywhere. Read this Q&A from Gavi CEO Dr Seth Berkley, where he explains why it is so important for countries to join the COVAX Pillar and how this […]
Application deadline extended: 17 July 2020 The COVAX Pillar – one of the four pillars of the Act-Accelerator – are seeking applications for its expert Independent Product Group. Objectives The Independent Product Group will be set up with the aim of establishing an independent process to advise the COVAX Facility and the COVAX Pillar more […]
EOI closes July 24, 2020 – Unitaid and FIND are calling for expressions of interest (EOI) to accelerate the availability and manufacturing scale-up of rapid diagnostic tests for the detection of SARS-CoV-2 antigens. This EOI is has been prepared in the context of the Access to COVID-19 Tools (ACT) Accelerator Diagnostics Pillar. Launched by FIND and Unitaid, it supports the […]
